Standard dosing protocols begin at 2.5 mg per week (as a titration dose) and escalate in 2.5 mg increments up to 15 mg per week, with each increase separated by at least four weeks
In short, semaglutide hit the market nearly a decade ago in 2017
Similarly, TZDs are as effective as GLP-1RAs in HbA 1C reduction, have fewer GI effects and may have a lower hypoglycaemia risk, but can cause weight gain
For many patients, semaglutide's superior weight loss benefits outweigh its steeper initial tolerability curve
Tolerability: For some users, semaglutide may cause fewer gastrointestinal side effects compared to Mounjaro
Take front, side, and back photos in consistent lighting